ECMO venovenosa: indicações e possíveis complicações em pacientes adultos
Carregando...
Data
2021
Tipo de documento
Artigo Científico
Título da Revista
ISSN da Revista
Título de Volume
Área do conhecimento
Ciências da Saúde
Modalidade de acesso
Acesso fechado
Editora
Autores
Maria, Neire
Orientador
Rodovalho, Aurélio
Coorientador
Resumo
Em meio ao caos de doenças respiratórias agudas graves (SRAGS), tais como H1N1 e Covid-19, a circulação extracorpórea atua como assistência respiratória extracorpórea através da ECMO Venovenosa proporcionando oxigenação do sangue e eliminação do dióxido de carbono, com “repouso” pulmonar. Objetivo geral: enumerar indicações de ECMO Venovenosa e possíveis complicações em pacientes adultos. Metodologia: pesquisa bibliográfica, através de livros, plataformas eletrônicas gratuitas, a saber, PUBMED, diretrizes internacionais, dentre outros, publicados em português e inglês, entre os anos 2000 a 2021. A estratégia de busca de artigos na plataforma PubMed incluiu os termos: (“Extracorporeal Membrane Oxygenation” OR “ECMO VV”) AND (“complications” OR “clinical alterations” OR “artificial lungs” OR “survival”), com filtros “texto integral gratuito”, publicados nos últimos dez anos”, “idiomas inglês e português). A pesquisa identificou 191 artigos potencialmente relevantes, selecionando-se 15 artigos pertinentes para análise após triagem. Considerações finais: Complicações advindas do uso de ECMO VV são recorrentes, incluindo hemorragia intracraniana, complicações neurológicas, lesão renal aguda e infecções. Assim, a equipe multiprofissional envolvida deve focar aumentar a sobrevida bem como a qualidade de vida após o desmame da ECMO, sendo os responsáveis por informar sobre riscos e benefícios da ECMO VV, tornando esta terapia acessível econômica e politicamente dentro das comunidades acometidas pelas síndromes respiratórias.
PALAVRAS-CHAVE: ECMO Venovenosa. Indicações. Complicações. Pacientes adultos.
ABSTRACT In the environment of chaos of severe acute respiratory diseases (SRAGS), such as H1N1 and Covid-19, extracorporeal circulation acts as extracorporeal respiratory assistance through the Venovenous ECMO providing blood oxygenation and elimination of carbon dioxide, promoting pulmonary “rest”. General objective: to list indications for Venovenous ECMO and possible complications in adult patients. Methodology: bibliographical research, through books, free electronic platforms, in our case PUBMED, international guidelines, among others, published in Portuguese and English, from 2005 to 2021. The search strategy for articles on the PubMed platform included the terms: (“Extracorporeal Membrane Oxygenation” OR “ECMO VV”) AND (“complications” OR “clinical alterations” OR “artificial lungs” OR “survival”), with filters “free full text”, published in the last ten years”, “languages English and Portuguese). The search identified 191 potentially relevant articles, selecting 15 pertinent articles for analysis after screening. Final considerations: Complications arising from the use of ECMO VV are recurrent, including intracranial hemorrhage, neurological complications, acute kidney injury and infections. Thus, the multidisciplinary team involved should focus on increasing survival as well as quality of life after weaning from ECMO, being responsible for informing about the risks and benefits of ECMO VV, making this therapy affordable and politically accessible within communities affected by respiratory syndromes. KEYWORDS: Venovenous ECMO. Indications. Complications. Adult patients.
ABSTRACT In the environment of chaos of severe acute respiratory diseases (SRAGS), such as H1N1 and Covid-19, extracorporeal circulation acts as extracorporeal respiratory assistance through the Venovenous ECMO providing blood oxygenation and elimination of carbon dioxide, promoting pulmonary “rest”. General objective: to list indications for Venovenous ECMO and possible complications in adult patients. Methodology: bibliographical research, through books, free electronic platforms, in our case PUBMED, international guidelines, among others, published in Portuguese and English, from 2005 to 2021. The search strategy for articles on the PubMed platform included the terms: (“Extracorporeal Membrane Oxygenation” OR “ECMO VV”) AND (“complications” OR “clinical alterations” OR “artificial lungs” OR “survival”), with filters “free full text”, published in the last ten years”, “languages English and Portuguese). The search identified 191 potentially relevant articles, selecting 15 pertinent articles for analysis after screening. Final considerations: Complications arising from the use of ECMO VV are recurrent, including intracranial hemorrhage, neurological complications, acute kidney injury and infections. Thus, the multidisciplinary team involved should focus on increasing survival as well as quality of life after weaning from ECMO, being responsible for informing about the risks and benefits of ECMO VV, making this therapy affordable and politically accessible within communities affected by respiratory syndromes. KEYWORDS: Venovenous ECMO. Indications. Complications. Adult patients.
Palavras-chave
ECMO VENOVENOSA, INDICAÇÕES, Complicações, Pacientes adultos